Type of report: Global
Some initiatives are aligned with a particular phase in the medicine lifecycle, such as drug discovery or clinical trials, while others span several phases. The Patient Engagement and Medicines Lifecycle Matrix maps the levels of involvement or partnership against the corresponding phase (or phases) ofthe medicine lifecycle.
Based on 231 Initiatives
SYNaPsE, the patient engagement landscape mapping project, aims to provide an efficient mechanism for accessing information on what patient engagement activities are ongoing or planned, and to identify challenges encountered and lessons learned.
Get the latest information on Patient Focused Medicines Development and stay connected with our activities.